Literature DB >> 9455525

Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals.

D Cadavid1, A G Barbour.   

Abstract

The spirochetal disease relapsing fever is caused by different Borrelia species. Relapsing fever is well recognized as an infection of the blood, but little is known about its predilection for the nervous system and the eyes. To investigate neurological and ocular involvement during relapsing fever, we reviewed the clinical manifestations, pathology, and treatment of relapsing fever of humans and experimental animals. The results indicate that Borrelia turicatae and Borrelia duttonii, the agents of tick-borne relapsing fever in southwestern North America and sub-Saharan Africa, respectively, cause neurological involvement as often as Borrelia burgdorferi in Lyme disease. Evidence of this is the frequent occurrence of lymphocytic meningitis and peripheral facial palsy in human disease; the identification of spirochetes in the brain and other nervous tissues of humans, animals, and arthropod vectors; and the persistence of brain infection after treatment with antibiotics that do not readily penetrate the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9455525     DOI: 10.1086/516276

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  50 in total

1.  Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever.

Authors:  Raja Vuyyuru; Hongqi Liu; Tim Manser; Kishore R Alugupalli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system.

Authors:  Nilay Sethi; Marie Sondey; Yunhong Bai; Kwang S Kim; Diego Cadavid
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

3.  Cerebral sinuvenous thrombosis associated with Lyme neuroborreliosis.

Authors:  Michael Adamaszek; Alexander Heinrich; Andreas Rang; Sönke Langner; Alexander V Khaw
Journal:  J Neurol       Date:  2009-11-26       Impact factor: 4.849

4.  Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice.

Authors:  P M Pennington; D Cadavid; A G Barbour
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Interleukin 10 protects the brain microcirculation from spirochetal injury.

Authors:  Diana Londoño; Jenny Carvajal; Carolina Arguelles-Grande; Adriana Marques; Diego Cadavid
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

6.  Tick-borne relapsing fever: conjunctival haemorrhages.

Authors:  Luis Castilla-Guerra; Jesus Alvarez-Suero; Maria Del Carmen Fernandez-Moreno; Esther Roldan Fontana
Journal:  BMJ Case Rep       Date:  2009-02-20

7.  Efficient B cell responses to Borrelia hermsii infection depend on BAFF and BAFFR but not TACI.

Authors:  Gregory S Dickinson; Guizhi Sun; Richard J Bram; Kishore R Alugupalli
Journal:  Infect Immun       Date:  2013-11-11       Impact factor: 3.441

8.  Tickborne relapsing fever diagnosis obscured by malaria, Togo.

Authors:  Annika Nordstrand; Ignas Bunikis; Christer Larsson; Kodjo Tsogbe; Tom G Schwan; Mikael Nilsson; Sven Bergström
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

9.  Interaction of variable bacterial outer membrane lipoproteins with brain endothelium.

Authors:  Gaurav Gandhi; Diana Londoño; Christine R Whetstine; Nilay Sethi; Kwang S Kim; Wolfram R Zückert; Diego Cadavid
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

10.  Borrelia hispanica relapsing fever, Morocco.

Authors:  M'hammed Sarih; Martine Garnier; Najma Boudebouch; Ali Bouattour; Abdelaziz Rihani; Mohammed Hassar; Lise Gern; Danièle Postic; Muriel Cornet
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.